Don't Overreact to Dimon's Health Scare


Jim Cramer

 | Jul 02, 2014 | 11:24 AM EDT
  • Comment
  • Print Print
  • Print

Jamie Dimon is a revered banker, mostly because JPMorgan Chase (JPM) made a lot of right moves in the last few years, chiefly building up a fortress balance sheet that shielded the company from the big losses that so many other banks have taken. That's why the sad news that he has throat cancer is causing the stock of this Action Alerts PLUS name to get hit today.

Should the stock be bought into the weakness?...505 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.

Read the full story and get access to the Real Money trading floor.
There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. Staffed with nearly 3 dozen investing pros, money managers, journalists and analysts, Real Money gives you a flood of opinions, analysis and trading advice found nowhere else, and allows you to interact directly with each expert.

Already a Subscriber? Please Login
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.